Nagafuji K, Ito Y, Miyamoto T, Eto T, et al. Clinical Impact of Continuous Dasatinib Administration on the Prognosis of Patients With BCR::ABL1 Acute Lymphoblastic Leukemia: Result of the Prospective MRD2014 Study Conducted by Fukuoka Blood and Marrow Transplantation Group (FBMTG). Eur J Haematol 2025 Mar 7. doi: 10.1111/ejh.14407.
PMID: 40052397